“Hemic and Lymphatic Diseases” Search | National Guideline Clearinghouse

Search | National Guideline Clearinghouse

• National Sickle Cell Month (see related guidelines)

1-9 of 9 results for

“Hemic and Lymphatic Diseases”

• GUIDELINE SUMMARY
   
• NGC:010652
   
• 2014 MAR 15

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

American Thoracic Society

Compare

• GUIDELINE SUMMARY
   
• NGC:010534
   
• 2014

Blood transfusion in the management of sickle cell disease. In: Evidence-based management of sickle cell disease.

National Heart, Lung, and Blood Institute (U.S.)

Compare

• GUIDELINE SUMMARY
   
• NGC:009196
   
• 2012 JUN

Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
   
• NGC:010531
   
• 2014

Managing acute complications of sickle cell disease. In: Evidence-based management of sickle cell disease.

National Heart, Lung, and Blood Institute (U.S.)

Compare

• GUIDELINE SUMMARY
   
• NGC:010532
   
• 2014

Managing chronic complications of sickle cell disease. In: Evidence-based management of sickle cell disease.

National Heart, Lung, and Blood Institute (U.S.)

Compare

• GUIDELINE SUMMARY
   
• NGC:009350
   
• 2012 JAN-FEB

National Athletic Trainers' Association position statement: preventing sudden death in sports.

National Athletic Trainers' Association

Compare

• GUIDELINE SUMMARY
   
• NGC:011041
   
• 2016

Patient blood management guidelines: module 6 - neonatal and paediatrics.

National Blood Authority

Compare

• GUIDELINE SUMMARY
   
• NGC:010530
   
• 2014

Health maintenance for people with sickle cell disease. In: Evidence-based management of sickle cell disease.

National Heart, Lung, and Blood Institute (U.S.)

Compare

• GUIDELINE SUMMARY
   
• NGC:010533
   
• 2014

Hydroxyurea therapy in the management of sickle cell disease. In: Evidence-based management of sickle cell disease.

National Heart, Lung, and Blood Institute (U.S.)